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Visualizing Antigen-Specific and
Infected Cells in Situ Predicts
Outcomes in Early Viral Infection
Qingsheng Li,1 Pamela J. Skinner,2 Sang-Jun Ha,3 Lijie Duan,1 Teresa L. Mattila,2 Aaron Hage,2
Cara White,2 Daniel L. Barber,4 Leigh O’Mara,3 Peter J. Southern,1 Cavan S. Reilly,5
John V. Carlis,6 Christopher J. Miller,7 Rafi Ahmed,3 Ashley T. Haase1*
In the early stages of viral infection, outcomes depend on a race between expansion of
infection and the immune response generated to contain it. We combined in situ tetramer
staining with in situ hybridization to visualize, map, and quantify relationships between immune
effector cells and their targets in tissues. In simian immunodeficiency virus infections in macaques
and lymphocytic choriomeningitis virus infections in mice, the magnitude and timing of the
establishment of an excess of effector cells versus targets were found to correlate with the extent of
control and the infection outcome (i.e., control and clearance versus partial or poor control and
persistent infection). This method highlights the importance of the location, timing, and magnitude
of the immune response needed for a vaccine to be effective against agents of persistent infection,
such as HIV-1.
Theoutcome of viral infections in the acutestage of infection can be thought of as anumbers game and race, with the magni-
tude and speed of mounting host defenses com-
peting against virus propagation and spread (1).
Generally, in self-limited and fully controlled in-
fections, the host wins by quickly generating large
numbers of virus-specific cytotoxic T lymphocytes
(CTLs) that terminate infection by clearing in-
fected cells. However, a virus can win, and can
establish a persistent infection, when the cellular
immune response is delayed and is of insuffi-
cient magnitude to clear infection. The outcome
then depends on the extent to which the CTL re-
sponse can control infection and prevent progres-
sion to disease.
We studied correlates of these different out-
comes of infection in simian immunodeficiency
virus (SIV) and lymphocytic choriomeningitis
virus (LCMV) infections. SIV (and HIV-1) cause
persistent infections in which the CTL response
in the early stages of infection (2, 3) is too little
and too late (4–7) to prevent systemic infection
and massive depletion of CD4+ T cells in the gut
(8–10), but is usually sufficient to partially con-
trol virus production (2, 3). LCMV strains cause
infections in which the outcome may be clear-
ance or persistence, depending on the strain: In-
fection with LCMV-Armstrong is cleared from
adult C57B1/6 mice by 8 days post-inoculation
(dpi), whereas animals infectedwith LCMV–clone
13 remain persistently viremic for months (11, 12).
To identify correlates of clearance and the ex-
tent of control in persistent infections, we investi-
gated the relationship between increasing numbers
of infected cells and virus-specific CTLs in the early
stages of SIV and LCMV infections. We hypoth-
esized that the outcomes of infection would be
determined by the timing, ratio, and spatial colocal-
ization of virus-specific CTLs to infected cells. We
tested this hypothesis with a method (13) called
ISTH, as it combines in situ tetramer (IST) staining
(14) and in situ hybridization (ISH) to locate and
enumerate virus-specific tetramer+ T cells and viral
RNA+ cells in tissues, using these as measures, re-
spectively, of virus-specific CTLs and infected cells.
After intravaginal inoculation of SIV into
adult female rhesus macaques, virus replicates in
the first week in cervical vaginal tissues and then
spreads throughout the lymphatic tissues to reach
a peak in numbers of infected cells at 10 to 14 dpi
(8, 15). The peak in viral replication precedes the
cellular immune response to immunodominant
epitopes in SIV Gag and Tat that together con-
stitute 70% of the cellular immune response in
acute infection (16). This response is not detected
until 14 dpi (7), which is too late to prevent a
robust systemic infection. However, numbers of
SIVRNA+ cells do decline between 14 and 28 dpi,
at a time coinciding with the detection of increas-
ing numbers of Gag- and Tat-tetramer+ cells by
fluorescence-activated cell sorting (FACS) anal-
ysis and IST staining (7).
This decline in SIVRNA+ cells was greater in
cervical vaginal tissues than in lymphatic tissues
(15), consistent with the hypothesis that the ex-
tent of control in each tissue compartment was
related to the spatial proximity and numbers of
tetramer+ cells relative to the numbers of SIV
RNA+ cells.We used ISTH to test this hypothesis
by visualizing, in the same section, effector (E)
tetramer+ cells and target (T) SIV RNA+ cells,
and then determining E:T cell ratios and the spa-
tial proximity of tetramer+ cells to their targets in
cervical vaginal and lymphatic tissues (13).
We indeed found that the decline in numbers
of infected cells in the cervix between the peak
and 21 dpi (fig. S1, A and B) was correlated with
detection by ISTH (Fig. 1A) of Gag-tetramer+
cell–SIV RNA+ cell conjugates. The decline in
SIV RNA+ cells in lymphatic tissues was also
correlated with increasing numbers of tetramer+
cells in close proximity to infected cells, illustrated
for a lymph node at 21 dpi in Fig. 1B. We cap-
tured the spatial relationships between tetramer+
and SIV RNA+ cells in this lymph node by in-
dependently plotting their positions on a two-
dimensional plane (13). In the montage of the
whole lymph node section shown in Fig. 1B,
arrows in the enlarged inset from the encircled
area of the montage point to a red Gag-tetramer+
cell and a blue SIV RNA+ cell. The positions of
these Gag-tetramer+ cells are outlined against a
gray-white mask of the section in Fig. 2A, and
the positions of the Gag-tetramer+ cell centers
(centroids) are plotted in the upper panel of Fig.
2B. The positions of SIV RNA+ cells in this sec-
tion are plotted in the middle panel of Fig. 2B.
The lower panel shows, in the superimposition of
the upper and middle panels, Gag-tetramer+ cells
and SIV RNA+ cells in close spatial proximity to
one another throughout the lymph node. We thus
conclude that effectors and targets are in close spa-
tial proximity in these two tissue compartments.
By using ISTH to determine E:T ratios, we
could further show that these ratios correlated with
the extent of virus control in each tissue compart-
ment. Defining extent of control as the reduction
from peak numbers of copies of SIV RNA per
microgram of tissue RNA to copy numbers at 20,
21, and 28 dpi, when the animals had mounted a
tetramer response and viral load data were avail-
able from previously reported studies (15), we
found a statistically significant relationship be-
tween the E:T ratio and relative reduction (P =
0.001). Reductions in viral loads by a factor of 80
to 160 were correlated with E:T ratios of ≥100.
These ratios, with one exception, were achieved
only in the female reproductive tract tissues where
initial exposure and virus replication had elicited
the most robust response.
We next investigated the relationship between
the timing andmagnitude of the effector response
to infection outcome in LCMV-Armstrong and
LCMV–clone 13 infections. LCMV-Armstrong in-
fections are rapidly cleared by the second week of
infection, whereas LCMV–clone 13 infections con-
tinue at high levels for months, with debilitating
effects on virus-specific CTL proliferation and func-
tion mediated by programmed cell death–1 (PD-1)
and its ligands (11, 12, 15, 17). Because the two
amino acid differences between LCMV-Armstrong
and LCMV–clone 13 do not alter dominant or
subdominant epitopes (18, 19), it is not yet clear
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Fig. 1. ISTH analysis. (A) Cervical tissues, 21 dpi. The image of a whole
section of cervix was reconstructed as a montage in Photoshop from sep-
arate confocal images, using the red channel for the Gag-tetramer+ cells
and green for the SIV RNA+ cells. The blue arrow from the region enclosed
by the blue rectangle points to a red Gag-tetramer+ cell–green SIV RNA+
cell conjugate in the enlarged inset. The excess of Gag-tetramer+ cells is
shown in the inset in a region enclosed by the red rectangle. (B) Lymphatic
tissues, 21 dpi. Montage of a whole lymph node section reconstructed in
Photoshop from separate images, using the red channel for the Gag-
tetramer+ cells, blue for the SIV RNA+ cells, and green for CD8+ T cells.
The red arrow in the enlarged inset (upper left) points to a red Gag-
tetramer+ cell; the light blue arrow points to a blue SIV RNA+ cell. The two
lightened separate images with an encircled distinctive V-shaped con-
stellation of Gag-tetramer+ cells provide a frame of reference for Fig. 2.
Scale bars for whole sections, 50 mm; insets, 10 mm.
Fig. 2. Spatial relationships between SIV-
tetramer+ and SIV RNA+ cells in the lymph node
shown in Fig. 1B, and relationship between E:T
ratios and reduction in viral replication. (A) Gag-
tetramer+ cells are shown against a gray-white
mask of the section, with the V-shaped encircled
constellation shown in Fig. 1B. Scale bar, 50 mm.
(B) SIV RNA+ and tetramer+ cells were mapped by
plotting the x and y coordinates of their centers
(centroids) onto a two-dimensional grid measured
from a fixed starting position (0,0). Upper panel,
Gag-tetramer+ cells; middle panel, SIV RNA+ cells;
lower panel, superimpositionof upper andmiddle
panels revealing the close spatial proximity of the
virus-specific tetramer+ cells with SIV RNA+
throughout the lymph node. The white crosses
and encircled areas in the panels are included as
points of reference. (C) E:T ratio correlates with
reduction in viral load in cervical vaginal and
lymphatic tissues. Natural log–transformed viral
load fold reductions are plotted against E:T ratios
for Gag- and Tat-tetramer+ cells in cervical (CX)
and vaginal (Vag) tissues and lymph nodes (LN)
from five animals at 20 to 28 dpi. E:T ratios were
determined by ISH as described (13).
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Fig. 3. Time course comparison of cells infected by LCMV-
Armstrong or LCMV–clone 13. Outer columns: LCMV RNA+
cells detected by ISH with LCMV-specific probes have a
greenish appearance in developed radioautographs viewed
in reflected light. Spleen white pulp is counterstained dark
blue. Inner columns: LCMV-antigen+ cells are stained red
with polyclonal antibody to LCMV; FRCs in white pulp are
stained green with the FRC marker ER-TR7. Both viral strains
at 1 dpi (d1) infect macrophages in the marginal zone and
FRCs in the white pulp, but LCMV–clone 13 infects larger
numbers of both cell types. LCMV–clone 13 continues to
infect large numbers of both cell types over the 8-day time
course of the experiment, whereas the numbers of infected
cells rapidly decline in LCMV-Armstrong infections. Scale
bars (bottom row), 10 mm.
Fig. 4. (A) FACS analy-
sis of the immunodomi-
nant epitope response to
acute LCMV-Armstrong and
LCMV–clone 13 infections
in spleen. Flow cytometric
quantification is presented
as proportions and num-
bers of stained tetramer+
cells from disaggregated
spleensfromgroupsof three
mice per time point after
LCMV-Armstrong or LCMV–
clone 13 infection. Repre-
sentative plots gated on
CD8+ T cells are shown by
MHC class I tetramer (y axis)
for each immunodominant
epitope (GP33-41, GP276-
286, and NP396-404) and
CD44 (x axis). (B) E:T ratios
in acute LCMV-Armstrong
and LCMV–clone 13 infec-
tions in spleen. E:T ratios at
the times shownwere deter-
mined by ISTH as described
(13).
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why the initial CD8 Tcell response should result in
such divergent outcomes.
We determined by ISTH that strain LCMV-
Armstrong is cleared because the number of im-
mune effectors rapidly exceeds the number of
infected cells. LCMV–clone 13, on the other hand,
immediately infects larger numbers ofmacrophages
(18) and fibroreticular cells (FRCs) (20) than
does LCMV-Armstrong, thereby exceeding the
capacity of the initial immune response to reduce
the basic reproductive rate below 1 and thereby
contain infection.
The divergent outcome and larger number of
cells infected by LCMV–clone 13 in the spleen
are illustrated in Fig. 3, which tracks LCMVRNA+
cells and LCMV-antigen+ FRCs (13) in the spleen
from 1 to 8 dpi for the respective strains. As pre-
viously described, both strains of LCMV infect
splenic marginal zone macrophages and FRCs in
the white pulp, but LCMV–clone 13 infects larger
numbers of both cell types (18, 20). This dif-
ference, particularly the infection of FRCs, is
already evident at 1 dpi, as judged by the diffuse
ISH signal emanating from LCMVRNA+ cells in
the white pulp. LCMV–clone 13 infection of both
cell types is sustained at high levels at 3, 5, and
8 dpi, whereas the numbers of LCMV-Armstrong–
infected cells are barely detectable by 8 dpi.
The different infection outcomes produced by
these two strains of LCMV cannot be explained
by differences in the immune response seen in
FACS analysis, but can be explained by ISTH,
which provides the critical relevant measure of
relative rates of increase in effectors and targets.
By FACS analysis, the rapidly expanding pop-
ulations of virus-specific tetramer+ T cells were
comparable for both strains from 3 to 8 dpi (Fig.
4A). However, E:T ratios determined by ISH
reflect the increase of infected cells (relative to
LCMV-GP and NP-tetramer+ cells) in LCMV–
clone 13 infection versus LCMV-Armstrong in-
fection (Fig. 4B). Because of the faster increase
of infected cells relative to LCMV-tetramer+ cells,
the E:T ratio for LCMV–clone 13 never approached
1. By contrast, the E:T ratio for LCMV-Armstrong
was already ~4 at 3 dpi, higher than the ratio for
LCMV–clone 13 at 3 dpi by a factor of 20.
Together, the ISTHanalyses of SIVandLCMV
infection tell us that location, timing, and numbers
of effectors and targets all count in determining
outcome. We have speculated elsewhere (5) that if
the “too little, too late” response to SIV infection
(7) had occurred earlier, when there were only
small founder populations of infected cells con-
fined to the portal of entry, vaginal transmission
and systemic infection might be prevented with
relatively few effector cells. Thus, in SIV (and, by
extension, HIV-1) infections, a vaccine that elic-
ited an immune response at the portal of entry
“enough and soon enough” could prevent vaginal
transmission.
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Infection by Tubercular Mycobacteria
Is Spread by Nonlytic Ejection
from Their Amoeba Hosts
Monica Hagedorn,1 Kyle H. Rohde,2 David G. Russell,2 Thierry Soldati1*
To generate efficient vaccines and cures for Mycobacterium tuberculosis, we need a far better
understanding of its modes of infection, persistence, and spreading. Host cell entry and the
establishment of a replication niche are well understood, but little is known about how
tubercular mycobacteria exit host cells and disseminate the infection. Using the social amoeba
Dictyostelium as a genetically tractable host for pathogenic mycobacteria, we discovered
that M. tuberculosis and M. marinum, but not M. avium, are ejected from the cell through an
actin-based structure, the ejectosome. This conserved nonlytic spreading mechanism requires a
cytoskeleton regulator from the host and an intact mycobacterial ESX-1 secretion system.
This insight offers new directions for research into the spreading of tubercular mycobacteria
infections in mammalian cells.
Intracellular bacterial pathogens have evolvedstrategies to exploit host cell resources andreplicate inside a variety of cell types, staying
out of reach of the host’s immune system. The con-
cept is emerging that pathogenic bacteria evolved
from environmental species by adapting to an in-
tracellular lifestyle within free-living bacteria-eating
protozoans. Consequently, cellular defense mecha-
nisms that are active in animal immune phagocytes
may have originated in amoebas (1, 2). For exam-
ple, during differentiation of the social amoeba
Dictyostelium to form a multicellular structure, sen-
tinel cells are deployed to combat pathogens (1).
Generally, infection follows the entry of a bac-
terium into a host cell, giving rise to a pathogen-
containing vacuole usually called a phagosome.
From this common starting point, pathogens sub-
vert or resist the mechanisms that usually transform
the phagosome into a bactericidal environment.
Understanding of the passive or triggered uptake
mechanisms and of the subsequent hijacking of
host cell processes is increasing steadily, but little
is known about how the pathogens exit their pri-
mary host cells and spread the infection.
Mycobacterium tuberculosis causes tubercu-
losis and other granulomatous lesions and is a
major threat to human health. M. marinum is a
close relative (3) responsible for fish and am-
phibian tuberculosis, in which it causes almost
indistinguishable pathologies and lesions [reviewed
in (4)]. Several elegant cross-species complemen-
tation studies between these two pathogens high-
light their common mechanisms of pathogenicity
[reviewed in (4)].
After passive uptake by immune phagocytes,
M. tuberculosis and M. marinum arrest or by-
pass phago-lysosome maturation and replicate
inside a compartment of endosomal nature (5–7).
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